|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics
|
Luke Timmerman |
12/15/11 |
Boston
|
|
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund
|
Luke Timmerman |
10/17/11 |
San Francisco
|
|
Orexigen’s Diet Drug Springs Back to Life, Independa Gets $1.6M, NuVasive Faces Big Judgments in Patent Dispute, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/22/11 |
San Diego
|
|
Orexigen Revives Obesity Drug After One More Go-Round With FDA
|
Luke Timmerman |
09/20/11 |
San Diego
|
|
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead
|
Luke Timmerman |
09/06/11 |
National
|
|
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials
|
Arlene Weintraub |
07/07/11 |
Boston
|
|
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/09/11 |
San Diego
|
|
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank
|
Luke Timmerman |
06/03/11 |
San Diego
|
|
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/02/11 |
San Diego
|
|
Optimer Antibiotic Gets Panel Nod, CareFusion Buys Vestara, Tracon Raises $16.5M, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/07/11 |
San Diego
|
|
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News
|
Bruce V. Bigelow |
02/10/11 |
San Diego
|
|
Orexigen Axes 40 Percent of Workforce After FDA Turns Down Obesity Drug
|
Luke Timmerman |
02/09/11 |
San Diego
|
|
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
02/03/11 |
San Diego
|
|
Orexigen Fails to Win FDA Approval of Obesity Drug, Stock Crashes
|
Luke Timmerman |
02/01/11 |
San Diego
|
|
San Diego’s Fight Against Diabesity: The Photo Gallery
|
Luke Timmerman |
01/28/11 |
San Diego
|
|
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug
|
Luke Timmerman |
01/27/11 |
San Diego
|
|
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug
|
Luke Timmerman |
01/21/11 |
San Diego
|
|
Zafgen Weight Loss Drug Shows Promise in First Human Test
|
Luke Timmerman |
01/05/11 |
Boston
|
|
FDA Panel Recommends Orexigen’s Obesity Drug, Sequenom Raises Capital, CommNexus Reorganizes Its Free Incubator, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
12/09/10 |
San Diego
|
|
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug
|
Luke Timmerman |
12/07/10 |
San Diego
|
|
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive?
|
Luke Timmerman |
12/03/10 |
San Diego
|
|
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny?
|
Luke Timmerman |
11/22/10 |
San Diego
|
|
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing
|
Luke Timmerman |
10/25/10 |
San Diego
|
|
Arena Obesity Drug Was Effective by ‘Slim Margin,’ FDA Staff Raises Rat Cancer Concern; Shares Tumble
|
Luke Timmerman |
09/14/10 |
San Diego
|
|
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News
|
Bruce V. Bigelow |
09/09/10 |
San Diego
|
|
Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb
|
Luke Timmerman |
09/02/10 |
San Diego
|
|
Tethys Pockets $33M, Achaogen’s Vision for Antibiotics, Genentech Strikes Out at FDA Panel, & More Bay Area Life Sciences News
|
Luke Timmerman |
07/23/10 |
San Francisco
|
|
Cypress Bio Gets Buyout Offer, Trius Prepares for IPO, Arena Gains Following Vivus Setback, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
07/22/10 |
San Diego
|
|
Euthymics, Led by Orexigen Vet, Nabs $24M for Depression Drug With Fewer Side Effects
|
Luke Timmerman |
07/22/10 |
Boston
|
|
Lessons Learned About the Outlook for New Obesity Drug Approval
|
Tom Hughes |
07/16/10 |
National
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.